Increasing Cases of Influenza in the U.S. Is Driving the Growth of the Market

 

U.S. Influenza Vaccines Market
U.S. Influenza Vaccines Market

U.S. Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines, Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A, Influenza Virus Type B), by Age Group (Pediatrics, Adults) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030.

Market Overview:

Influenza, commonly known as the flu, is a severely contagious respiratory disease caused by the influenza virus. It can cause mild to severe illness, and in some cases, can even be fatal. The symptoms of influenza can include fatigue, chills, headache, body aches, stuffy or runny nose, sore throat, cough and fever. Influenza is typically spread through respiratory droplets. The best way to prevent influenza is by getting an annual flu vaccine and practicing good hygiene, such as washing hands frequently and covering coughs and sneezes.

Influenza can be a serious and potentially life-threatening illness, especially in certain high-risk groups such as young children, elderly adults, pregnant women, and individuals with weakened immune systems or underlying health conditions. Complications of influenza can include pneumonia, bronchitis, sinus infections, ear infections, and worsening of chronic medical conditions such as asthma and heart disease. In severe cases, influenza can lead to hospitalization and even death.

Competitive Landscape:

Major players operating in the U.S. influenza vaccines market include EMERGENT, Novavax, INOVIO Pharmaceuticals, Moderna, Inc., Protein Sciences Corporation, Merck & Co., Inc., Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, GSK plc., and Seqirus USA Inc.

Key Market Drivers:

The major drivers of the U.S. influenza vaccines market include the increasing incidence of influenza infections, the growing awareness about the importance of vaccination in preventing seasonal flu, and the rise in government initiatives to promote immunization programs. For instance, according to Forbes, in 2021, there were around 9 million cases of influenza in the United States.

The emergence of new strains of the influenza virus is also estimated to enhance the growth of the U.S. influenza vaccines market. Additionally, the growing elderly population, which is more susceptible to influenza, is expected to drive the demand for influenza vaccines in the U.S. Covid-19 Impact Analysis:

The COVID-19 pandemic has had a significant impact on the U.S. influenza vaccines market. Due to the COVID-19 pandemic, there has been a significant increase in the demand for influenza vaccines as people become more aware of the importance of vaccination in preventing infectious diseases. The COVID-19 pandemic has also led to an increase in the use of telemedicine and virtual consultations, which has facilitated the distribution of influenza vaccines.

Key Takeaways:

·         High awareness related to vaccination U.S. is expected to dominate the growth of the U.S. influenza vaccines market. For instance, according to the Centers for Disease Control and Prevention, there were around 5000 deaths in the U.S. due to influenza.

·         The increasing prevalence of the geriatric population in the U.S. is estimated to augment the growth of the U.S. influenza vaccines market. For instance, according to the U.S. Census Bureau, there are over 56 million elderly individuals in the U.S. (65 years or more).

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C...
Read more